{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:19:44Z","timestamp":1784996384621,"version":"3.55.0"},"reference-count":21,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12,1]]},"DOI":"10.1210\/jc.2013-2975","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T15:51:13Z","timestamp":1381420273000},"page":"4834-4844","source":"Crossref","is-referenced-by-count":64,"title":["The Clinical Course of Treated Hyperparathyroidism Among Patients Receiving Hemodialysis and the Effect of Cinacalcet: The EVOLVE Trial"],"prefix":"10.1210","volume":"98","author":[{"given":"Patrick S.","family":"Parfrey","sequence":"first","affiliation":[{"name":"Health Sciences Center (P.S.P.), St. John's, Newfoundland, Canada A1B 3V6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine (G.M.C.), Palo Alto, California 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Block","sequence":"additional","affiliation":[{"name":"Denver Nephrology (G.A.B.), Denver, Colorado 20230"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Correa-Rotter","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n (R.C.-R.), Mexico City, Mexico D.F. 140100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman B.","family":"Dr\u00fceke","sequence":"additional","affiliation":[{"name":"Inserm Unit 1088, UFR M\u00e9decine\/Pharmacie (T.B.D.), Universit\u00e9 de Picardie, 80037 Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum der RWTH Aachen (J.F.), 52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Herzog","sequence":"additional","affiliation":[{"name":"University of Minnesota (C.A.H.), Minneapolis, Minnesota 55415"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard M.","family":"London","sequence":"additional","affiliation":[{"name":"H\u00f4pital Manh\u00e8s (G.M.L.), Paris, France 91712"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Mahaffey","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute (K.W.M.), Duke University Medical Center, Durham, North Carolina 27705"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Moe","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine and Roudebush Veterans Administration Medical Center (S.M.M.), Indianapolis, Indiana 46202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"University College London (D.C.W.), London, United Kingdom NW32PF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Dehmel","sequence":"additional","affiliation":[{"name":"Amgen, Inc (B.D., M.-L.T., D.M.M., W.G.G.), Thousand Oaks, California 91320"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Trotman","sequence":"additional","affiliation":[{"name":"Amgen, Inc (B.D., M.-L.T., D.M.M., W.G.G.), Thousand Oaks, California 91320"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M.","family":"Modafferi","sequence":"additional","affiliation":[{"name":"Amgen, Inc (B.D., M.-L.T., D.M.M., W.G.G.), Thousand Oaks, California 91320"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Goodman","sequence":"additional","affiliation":[{"name":"Amgen, Inc (B.D., M.-L.T., D.M.M., W.G.G.), Thousand Oaks, California 91320"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041117344705800_B1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"2019041117344705800_B2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"2019041117344705800_B3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"2019041117344705800_B4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1542-4758.2007.00190.x","article-title":"Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study","volume":"11","author":"Kimata","year":"2007","journal-title":"Hemodial Int"},{"key":"2019041117344705800_B5","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2019041117344705800_B6","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2019041117344705800_B7","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int"},{"key":"2019041117344705800_B8","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1681\/ASN.V1261242","article-title":"Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study","volume":"12","author":"Malberti","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2019041117344705800_B9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1523-1755.2004.00368.x","article-title":"Parathyroidectomy rates among United States dialysis patients: 1990\u20131999","volume":"65","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"},{"key":"2019041117344705800_B10","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"2019041117344705800_B11","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/ndt\/gfh966","article-title":"Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl","volume":"20","author":"Moe","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2019041117344705800_B12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5414\/CNP69269","article-title":"An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism","volume":"69","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"2019041117344705800_B13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized trial to evaluate the effects of cinacalcet plus low dose vitamin D on vascular calcification in patients in hemodialysis","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2019041117344705800_B14","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"2019041117344705800_B15","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","article-title":"Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview","volume":"2","author":"Chertow","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019041117344705800_B16","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1093\/ndt\/gfr777","article-title":"Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial","volume":"27","author":"Chertow","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2019041117344705800_B17","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"EVOLVE Trial Investigators","year":"2012","journal-title":"N Engl J Med"},{"key":"2019041117344705800_B18","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2019041117344705800_B19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00268-006-0693-1","article-title":"Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism","volume":"31","author":"Trombetti","year":"2007","journal-title":"World J Surg"},{"key":"2019041117344705800_B20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/hed.21757","article-title":"Outcomes after thyroidectomy and parathyroidectomy","volume":"34","author":"Gupta","year":"2012","journal-title":"Head Neck"},{"key":"2019041117344705800_B21","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","article-title":"Survival following parathyroidectomy among United States dialysis patients","volume":"66","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/12\/4834\/11128131\/jcem4834.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T18:16:34Z","timestamp":1646763394000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/12\/4834\/2834683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,1]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-2975","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,1]]}}}